Literature DB >> 20522639

Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.

Juan C Canale-Zambrano1, Meagan L Auger, Christina K Haston.   

Abstract

Toll-like receptor (Tlr) 4 is a lipopolysaccharide (LPS) receptor that contributes to the regulation of intestinal cell homeostasis, a condition that is altered in the intestines of cystic fibrosis mice. Herein, we assessed whether Tlr4 genotype influences cystic fibrosis intestinal disease by producing and phenotyping 12-wk (adult)- and 4-day (neonate)-old mice derived from BALB cystic fibrosis transmembrane conductance regulator, Cftr(+/tm1Unc) and C.C3-Tlr4(Lps-d)/J (Tlr4(-/-)), progenitors. Intestinal disease was assayed through mouse survival, crypt-villus axis (CVA) length, cell proliferation, bacterial load, bacterial classification, inflammatory cell infiltrate, and mucus content measures. Of the 77 Cftr(-/-) (CF) mice produced, only one Cftr/Tlr4 double-mutant mouse lived to the age of 12 wk while the majority of the remainder succumbed at approximately 4 days of age. The survival of CF Tlr4(+/-) mice exceeded that of both CF Tlr4(+/+) and Cftr/Tlr4 double-mutant mice. Adult CF mice presented increased Tlr4 expression, CVA length, crypt cell proliferation, and bacterial load relative to non-CF mice, but no differences were detected in Tlr4(+/-) compared with Tlr4(+/+) CF mice. The double-mutant neonates did not differ from Tlr4(+/+) or Tlr4(+/-) CF mice by intestinal CVA length or bacterial load, but fewer Tlr4(+/-) CF neonates presented with luminal mucus obstruction in the distal ileum, and the intestinal mast cell increase of CF mice was not evident in double-mutant neonates. We conclude that Tlr4 deficiency reduces the survival, but does not alter the intestinal phenotypes, of extended CVA or increased bacterial load in BALB CF mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20522639     DOI: 10.1152/ajpgi.00003.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

2.  Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Racquel Mueller; Megan Boyd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

3.  Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.

Authors:  Dane Parker; Taylor S Cohen; Morten Alhede; Bryan S Harfenist; Francis J Martin; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

4.  Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice.

Authors:  Ilya Bederman; Aura Perez; Leigh Henderson; Joshua A Freedman; James Poleman; Dana Guentert; Nicholas Ruhrkraut; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

Review 5.  Animal models of cystic fibrosis in the era of highly effective modulator therapies.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico
Journal:  Curr Opin Pharmacol       Date:  2022-05-13       Impact factor: 4.768

6.  Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.

Authors:  Jinghua Liu; Nancy M Walker; Akifumi Ootani; Ashlee M Strubberg; Lane L Clarke
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

7.  Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells.

Authors:  Catriona Kelly; Paul Canning; Paul J Buchanan; Mark T Williams; Vanessa Brown; Dieter C Gruenert; J Stuart Elborn; Madeleine Ennis; Bettina C Schock
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

Review 8.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

9.  Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.

Authors:  Nancy M Walker; Jinghua Liu; Sarah M Young; Rowena A Woode; Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-12-08       Impact factor: 4.052

10.  Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.

Authors:  Mark Bazett; Marie-Eve Bergeron; Christina K Haston
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.